Tectonic Therapeutic (TECX) Tops Q2 EPS by 17c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Tweet
Share
E-mailGet Alerts TECX Hot Sheet
Join SI Premium – FREE
Tectonic Therapeutic (NASDAQ: TECX) reported Q2 EPS of ($1.18), $0.17 better than the analyst estimate of ($1.35).
For earnings history and earnings-related data on Tectonic Therapeutic (TECX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ServiceNow price target raised to $170 by Citi analyst
- RBC Capital Defending Axsome Therapeutics (AXSM): 'we would be buyers at these levels'
- JPMorgan Upgrades Paladin Energy (PDN:AU) (PALAF) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
